• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道黏膜纤毛功能障碍降低了 Claudin-4 靶向鼻用疫苗免疫接种后小鼠针对抗原的特异性 IgA 免疫应答。

Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice.

机构信息

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, 567-0085, Japan.

Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.

出版信息

Sci Rep. 2018 Feb 13;8(1):2904. doi: 10.1038/s41598-018-21120-7.

DOI:10.1038/s41598-018-21120-7
PMID:29440671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5811541/
Abstract

Vaccine delivery is an essential element for the development of mucosal vaccine, but it remains to be investigated how physical barriers such as mucus and cilia affect vaccine delivery efficacy. Previously, we reported that C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE) targeted claudin-4, which is expressed by the epithelium associated with nasopharynx-associated lymphoid tissue (NALT), and could be effective as a nasal vaccine delivery. Mice lacking tubulin tyrosine ligase-like family, member 1 (Ttll1-KO mice) showed mucus accumulation in nasal cavity due to the impaired motility of respiratory cilia. Ttll1-KO mice nasally immunized with C-CPE fused to pneumococcal surface protein A (PspA-C-CPE) showed reduced PspA-specific nasal IgA responses, impaired germinal center formation, and decreased germinal center B-cells and follicular helper T cells in the NALT. Although there was no change in the expression of claudin-4 in the NALT epithelium in Ttll1-KO mice, the epithelium was covered by a dense mucus that prevented the binding of PspA-C-CPE to NALT. However, administration of expectorant N-acetylcysteine removed the mucus and rescued the PspA-specific nasal IgA response. These results show that the accumulation of mucus caused by impaired respiratory cilia function is an interfering factor in the C-CPE-based claudin-4-targeting nasal vaccine.

摘要

疫苗传递是黏膜疫苗发展的一个重要因素,但物理屏障(如黏液和纤毛)如何影响疫苗传递效率仍有待研究。此前,我们报道了产气荚膜梭菌肠毒素 C 端片段(C-CPE)靶向 Claudin-4,Claudin-4 由与鼻咽相关淋巴组织(NALT)相关的上皮细胞表达,可作为鼻用疫苗传递的有效载体。微管酪氨酸连接酶样家族成员 1(Ttll1-KO)缺失的小鼠由于呼吸纤毛运动受损而导致鼻腔内黏液积聚。用与肺炎球菌表面蛋白 A(PspA-C-CPE)融合的 C-CPE 对 Ttll1-KO 小鼠进行鼻腔免疫接种,会导致 PspA 特异性鼻腔 IgA 反应减少、生发中心形成受损以及 NALT 中的生发中心 B 细胞和滤泡辅助 T 细胞减少。尽管 Ttll1-KO 小鼠的 NALT 上皮细胞中 Claudin-4 的表达没有变化,但上皮细胞被致密的黏液覆盖,阻止了 PspA-C-CPE 与 NALT 的结合。然而,给予化痰剂 N-乙酰半胱氨酸可去除黏液并恢复 PspA 特异性鼻腔 IgA 反应。这些结果表明,呼吸纤毛功能受损引起的黏液积聚是 C-CPE 靶向 Claudin-4 的鼻用疫苗的干扰因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/044e79510ba1/41598_2018_21120_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/0d9104f06159/41598_2018_21120_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/13b6abb9c83d/41598_2018_21120_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/4c1ec6dd6424/41598_2018_21120_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/044e79510ba1/41598_2018_21120_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/0d9104f06159/41598_2018_21120_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/13b6abb9c83d/41598_2018_21120_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/4c1ec6dd6424/41598_2018_21120_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b2/5811541/044e79510ba1/41598_2018_21120_Fig4_HTML.jpg

相似文献

1
Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice.气道黏膜纤毛功能障碍降低了 Claudin-4 靶向鼻用疫苗免疫接种后小鼠针对抗原的特异性 IgA 免疫应答。
Sci Rep. 2018 Feb 13;8(1):2904. doi: 10.1038/s41598-018-21120-7.
2
Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccine.黏液纤毛运动受损增强了对基于霍乱毒素的鼻用疫苗的抗原特异性鼻内IgA免疫反应。
Int Immunol. 2020 Jul 28;32(8):559-568. doi: 10.1093/intimm/dxaa029.
3
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine.用于鼻内肺炎球菌疫苗的C端产气荚膜梭菌肠毒素介导的抗原递送
PLoS One. 2015 May 27;10(5):e0126352. doi: 10.1371/journal.pone.0126352. eCollection 2015.
4
The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.应用丙型梭状芽孢杆菌肠毒素 C 末端片段的一个丙氨酸取代突变体作为黏膜疫苗在小鼠体内的应用。
Biomaterials. 2012 Jan;33(1):317-24. doi: 10.1016/j.biomaterials.2011.09.048. Epub 2011 Oct 7.
5
The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.使用产气荚膜梭菌肠毒素C末端片段的粘膜疫苗的安全性。
Pharmazie. 2010 Oct;65(10):766-9.
6
Mucosal vaccination using claudin-4-targeting.使用紧密连接蛋白 4 靶向的黏膜疫苗接种。
Biomaterials. 2010 Jul;31(20):5463-71. doi: 10.1016/j.biomaterials.2010.03.047.
7
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses.Claudin 4 靶向肽对 M 细胞的靶向作用可以增强黏膜 IgA 应答。
BMC Biotechnol. 2012 Mar 13;12:7. doi: 10.1186/1472-6750-12-7.
8
Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.一种靶向claudin的分子——产气荚膜梭菌肠毒素C末端片段的组织分布及安全性评估
Eur J Pharm Sci. 2014 Feb 14;52:132-7. doi: 10.1016/j.ejps.2013.10.018. Epub 2013 Nov 11.
9
Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.鼻腔接种肺炎球菌表面蛋白 A 联合由 DOTAP 和 DC-chol 组成的阳离子脂质体可在小鼠体内诱导针对肺炎链球菌感染的抗原介导的保护性免疫。
Int Immunopharmacol. 2018 Aug;61:385-393. doi: 10.1016/j.intimp.2018.06.027. Epub 2018 Jun 23.
10
Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.鼻腔内接种编码 P6 蛋白和免疫刺激复合物的质粒 DNA 可引发鼻咽部非典型流感嗜血杆菌特异性长期黏膜免疫应答。
Vaccine. 2011 Feb 24;29(10):1881-90. doi: 10.1016/j.vaccine.2010.12.129. Epub 2011 Jan 13.

引用本文的文献

1
Safety Assessment of a Sublingual Vaccine Formulated with Poly(I:C) Adjuvant and Influenza HA Antigen in Mice and Macaque Monkeys: Comparison with Intranasal Vaccine.聚肌胞苷酸(Poly(I:C))佐剂与流感血凝素(HA)抗原配制的舌下疫苗在小鼠和猕猴中的安全性评估:与鼻内疫苗的比较
Vaccines (Basel). 2025 Feb 28;13(3):261. doi: 10.3390/vaccines13030261.
2
M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity.靶向显示在类细菌颗粒上的幽门螺杆菌抗原SAM-FAdE的M细胞可诱导保护性免疫。
J Nanobiotechnology. 2025 Jan 18;23(1):23. doi: 10.1186/s12951-025-03111-9.
3
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.

本文引用的文献

1
Angubindin-1, a novel paracellular absorption enhancer acting at the tricellular tight junction.安古宾丁-1,一种新型的细胞旁渗透增强剂,作用于三细胞紧密连接。
J Control Release. 2017 Aug 28;260:1-11. doi: 10.1016/j.jconrel.2017.05.024. Epub 2017 May 18.
2
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine.用于鼻内肺炎球菌疫苗的C端产气荚膜梭菌肠毒素介导的抗原递送
PLoS One. 2015 May 27;10(5):e0126352. doi: 10.1371/journal.pone.0126352. eCollection 2015.
3
Bronchial lesions of mouse model of asthma are preceded by immune complex vasculitis and induced bronchial associated lymphoid tissue (iBALT).
利用 NALT 和 BALT 的潜力,通过工程策略作为免疫调节的靶点,以增强黏膜摄取。
Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024.
4
Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein.聚合咖啡酸通过与抗原蛋白形成复合物,作为黏膜疫苗制剂的抗原递送载体。
Vaccines (Basel). 2024 Apr 23;12(5):449. doi: 10.3390/vaccines12050449.
5
SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques.含RBD抗原和聚肌胞苷酸佐剂的新型冠状病毒2型舌下疫苗:食蟹猴的临床前研究
Biol Methods Protoc. 2023 Sep 13;8(1):bpad017. doi: 10.1093/biomethods/bpad017. eCollection 2023.
6
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice.新型靶向 SARS-CoV-2 受体结合域的鼻腔内疫苗,佐以 TLR3 激动剂 Riboxxim™,可在小鼠中引发强烈的抗体和 T 细胞反应。
Sci Rep. 2023 Mar 21;13(1):4648. doi: 10.1038/s41598-023-31198-3.
7
Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria Functions as an Effective Nasal Adjuvant to Augment IgA Antibody and Th17 Cell Responses.淋巴组织定居共生菌来源的脂多糖作为有效的鼻腔佐剂增强 IgA 抗体和 Th17 细胞应答。
Front Immunol. 2021 Jul 1;12:699349. doi: 10.3389/fimmu.2021.699349. eCollection 2021.
8
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.甲状腺乳头状癌中指示去分化的关键功能基因特征的鉴定
Front Oncol. 2021 Apr 28;11:641851. doi: 10.3389/fonc.2021.641851. eCollection 2021.
9
Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice.从各种前体酶聚合制备的多酚在小鼠的黏膜和系统隔室中增强了抗原特异性免疫应答。
PLoS One. 2021 Feb 8;16(2):e0246422. doi: 10.1371/journal.pone.0246422. eCollection 2021.
10
Chemically Synthesized Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of -Specific IgA and Th17 Mediated Protective Immunity.化学合成的脂多糖A显示出一种强大且安全的鼻用疫苗佐剂活性,可诱导特异性IgA和Th17介导的保护性免疫。
Microorganisms. 2020 Jul 23;8(8):1102. doi: 10.3390/microorganisms8081102.
哮喘小鼠模型的支气管病变之前会出现免疫复合物血管炎和诱导性支气管相关淋巴组织(iBALT)。
Lab Invest. 2015 Aug;95(8):886-902. doi: 10.1038/labinvest.2015.72. Epub 2015 Jun 1.
4
Nasal and pulmonary vaccine delivery using particulate carriers.鼻腔和肺部疫苗传递用颗粒载体。
Expert Opin Drug Deliv. 2015 Jun;12(6):993-1008. doi: 10.1517/17425247.2015.1044435. Epub 2015 May 8.
5
The effect of cilia and the mucociliary clearance on successful drug delivery.纤毛和黏液纤毛清除功能对药物递送成功的影响。
Biol Pharm Bull. 2015;38(4):497-506. doi: 10.1248/bpb.b14-00398. Epub 2015 Feb 7.
6
The mucosal immune system for vaccine development.用于疫苗研发的黏膜免疫系统。
Vaccine. 2014 Nov 20;32(49):6711-23. doi: 10.1016/j.vaccine.2014.08.089.
7
Molecular organization of tricellular tight junctions.三细胞紧密连接的分子组织
Tissue Barriers. 2014 May 1;2:e28960. doi: 10.4161/tisb.28960. eCollection 2014.
8
Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2--tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis.分析“angulin”蛋白 LSR、ILDR1 和 ILDR2——连接蛋白 tricellulin 的募集、上皮屏障功能及其在耳聋发病机制中的意义。
J Cell Sci. 2013 Feb 15;126(Pt 4):966-77. doi: 10.1242/jcs.116442. Epub 2012 Dec 13.
9
Ciliary and flagellar structure and function--their regulations by posttranslational modifications of axonemal tubulin.纤毛和鞭毛的结构和功能——它们通过轴丝微管的翻译后修饰来调节。
Int Rev Cell Mol Biol. 2012;294:133-70. doi: 10.1016/B978-0-12-394305-7.00003-3.
10
The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens.气道抗原采样系统:呼吸 M 细胞作为吸入抗原的另一种途径。
J Immunol. 2011 Apr 1;186(7):4253-62. doi: 10.4049/jimmunol.0903794. Epub 2011 Feb 28.